The programme aims to cover a range of topics to give a broad overview of the latest thinking and advances in the field of Hepatocellular carcinoma, from its diagnosis, treatments at various stages through to palliation.

Lectures will be for the whole team involved covering various medical disciplines delivered by leading UK experts. The continuing areas of controversy such as the role of biopsy and surveillance will be covered in the format of debates with the opportunity for audience participation. Now traditionally we continue with a ‘live’ multidisciplinary meeting in which a panel of experts will be presented with a series of cases and asked to define and justify the treatment plans.

Learning objectives


HCC UK Third Annual Conference has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 12 category 1 (external) CPD credit(s). Certificate of attendance will be provided to all participants upon request.

An outstanding educational programme covering the clinical management, current areas of controversy and the latest in fundamental research in the field of Hepatocellular Cancer.

HCC-UK comprises professionals of multidisciplines interested in improving outcomes for the increasing numbers of patients with hepatocellular carcinoma (HCC). The organisation primarily host this conference and forms a network of expertise in the research and treatment of HCC

Temporary HCC-UK Committee

Chair:  Aileen Marshall, London
Secretary: Tim Meyer, London
BASL Treasurer/BASL Nominee Tim Cross, Liverpool
Conference & Education: Abid Suddle, London
Basic Science: Matt Hoare, Cambridge
Hepatology: Aloysius Aravinthan, Nottingham
Oncology: Richard Hubner, Manchester
Surgery: Raaj Praseedom, Cambridge
Radiology: Mark Callaway, Bristol
Pathology: Dina Tiniakos, Newcastle

Members without portfolio:

Shishir Shetty, Birmingham
Teik Choon See, Cambridge
Helen Reeves, Newcastle